Alejandro R. Foley

Alejandro R. Foley

Auto-generated profile, based on publicly available information

Alejandro R. Foley

Department of Chemistry and Biochemistry , University of California Santa Cruz , Santa Cruz , California 95064 , United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SDSubrata Dutta
Subrata Dutta
AFAlejandro R. Foley
Alejandro R. Foley
CWChristopher J. A. Warner
Christopher J. A. Warner
XZXiaolin Zhang
Xiaolin Zhang
MRMarco Rolandi
Marco Rolandi
JRJevgenij A. Raskatov
Jevgenij A. Raskatov

2 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AFAlejandro R. Foley
Alejandro R. Foley
GRGraham P. Roseman
Graham P. Roseman
KCKa Chan
Ka Chan
ASAmanda Smart
Amanda Smart
TFThomas S. Finn
Thomas S. Finn
JRJevgenij A. Raskatov
Jevgenij A. Raskatov
Significance: Amyloid β (Aβ) aggregation has been the therapeutic target of several Alzheimer’s disease (AD) clinical trials. Aβ exists in many different aggregated forms, making it exceedingly challenging to target. Evidence links intracellular Aβ accumulation and AD pathogenesis. We report that amino acids 1 to 30 of Aβ, Aβ (1–30), do not aggregate yet display cellular uptake stereospecificity when compared to its mirror image, suggesting that Aβ uptake is predominantly receptor-mediated and may be independent from its aggregation state. Additionally, we found Aβ (1–30) internalization to depend on PrP C expression. Aβ (1–30) thus represents a powerful tool to study mechanisms of Aβ cellular internalization and suggests that Aβ uptake could be modulated by therapeutically targeting high-affinity Aβ receptors.

25 December 2019 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AFAlejandro R. Foley
Alejandro R. Foley
HLHsiau-Wei Lee
Hsiau-Wei Lee
JRJevgenij A. Raskatov
Jevgenij A. Raskatov

30 June 2016 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
CWChristopher J. A. Warner
Christopher J. A. Warner
SDSubrata Dutta
Subrata Dutta
AFAlejandro R. Foley
Alejandro R. Foley
JRJevgenij A. Raskatov
Jevgenij A. Raskatov
The amyloid beta peptide 42 (Aβ42) is an aggregation‐prone peptide that plays a pivotal role in Alzheimer′s disease. We report that a subtle perturbation to the peptide through a single chirality change at glutamate 22 leads to a pronounced delay in the β‐sheet adoption of the peptide. This was accompanied by an attenuated propensity of the peptide to form fibrils, which was correlated with changes at the level of the fibrillary architecture. Strikingly, the incorporation of d‐glutamate was found to stabilize a soluble, ordered macromolecular assembly with enhanced cytotoxicity to PC12 cells, highlighting the importance of advanced prefibrillary Aβ aggregates in neurotoxicity.

18 July 2019 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
AFAlejandro R. Foley
Alejandro R. Foley
TFThomas S. Finn
Thomas S. Finn
TKTimothy Kung
Timothy Kung
AHAsa Hatami
Asa Hatami
HLHsiau-Wei Lee
Hsiau-Wei Lee
JRJevgenij A. Raskatov
Jevgenij A. Raskatov

1 October 2021 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
AFAlejandro R. Foley
Alejandro R. Foley
JRJevgenij A. Raskatov
Jevgenij A. Raskatov